Mylan Laboratories Inc. (MYL) said Thursday its Mylan Pharmaceuticals Inc. unit received Food and Drug Administration approval for its Abbreviated New Drug Application for carvedilol tablets.
Carvedilol is the generic for GlaxoSmithKline PLC's (GSK) Coreg tablets.
Mylan, a Canonsburg, Pa. drug company, said about $1.65 billion of the tablets were sold in the U.S. in the year ending June 30.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment